小檗碱及其衍生物的研究进展  

Advances in the study of berberine and its derivatives

作　　者：李波[1] 朱维良[2] 陈凯先[1] 

机构地区：[1]上海中医药大学中药学院,上海201203 [2]中国科学院上海药物研究所药物发现与设计中心,上海201203

出　　处：《药学学报》2008年第8期773-787,共15页Acta Pharmaceutica Sinica

基　　金：国家重点基础研究计划(973计划)资助项目(2004CB518901);国家高技术研究发展计划(863计划)资助项目(2006AA02Z336)

摘　　要：小檗碱是从中草药黄连等植物中提取分离得到的一类异喹啉类生物碱。近十年来,已经有2000多篇国内外文献报道了小檗碱及其衍生物在治疗肿瘤、糖尿病、心血管疾病、高血脂、炎症、细菌和病毒感染、脑缺血性损伤、精神疾病、阿尔茨海默病(Alzheimer disease)、骨质疏松等多方面的临床应用、药效机制以及该类化合物的构效关系等研究结果。这些结果表明小檗碱生理功能广泛,潜在的结构改造和开发应用价值很大,但还未见系统的回顾和综述。本文对这些文献进行了系统地分析整理,主要从临床应用与药效机制、分子药理、体内吸收代谢、构效关系四个方面来介绍小檗碱及其衍生物的研究进展,旨在为进一步深入开展以药效机制为基础的小檗碱结构改造和创新药物研究提供比较系统的信息。Berberine is a isoquinoline alkaloid extracted from Chinese herbs such as Coptidis rhizome. In the past decade, there are more than 2 000 published papers studying the clinical application, pharmacodynamic mechanism and structure-activity relationship （SAR） of berberine and its derivatives, for treating tumor, diabetes, cardiavascellum disease, hyperlipemia, inflammation, bacterium and virus infection, cerebral ischemia trauma, mental disease, Alzheimer disease, osteoporosis, and so on. These results demonstrate that berberine has wide physiologic function and has great potential for structural modification as new drug lead. However, there is no systematic review about the study of berberine and its derivatives up to now. This paper is a systematic review of the research advances of berberine and its derevatives in clinical application, pharmacodynamic mechanisms, molecular pharmacology, absorption and metabolism, and SAR studies. The current review would provide some useful information for further study on structural modification of berberine for discovering new drug leads based on its pharmacodynamic mechanisms.

关 键 词：天然产物 小檗碱 衍生物 构效关系 药物设计 

分 类 号：R284[医药卫生—中药学]